Fig. 3From: Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumabKaplan-Maier OS curves of melanoma patients treated with nivolumab and stratified according to LDH and NLR (LDH cutoff = 455 mL/U; NLR cutoff = 5). Green line: only one factor below cutoffs; Yellow line: both factors over cutoffs; Blue line: Both factors below cutoffsBack to article page